RECRUITING

Change in Stroke Volume Index After Diuresis for Patients With Decompensated Heart Failure

Talk to us

Conditions

Acute Decompensated Heart Failure

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a prospective cohort study for 50 patients admitted to the cardiac care unit requiring clinically-indicated diuretic therapy for congestive heart failure. The purpose of this study is to assess the role of non-invasive cardiac output monitoring (NICOM) with the Starling Fluid Management System (Baxter Medical, Deerfield, IL) in determining volume status in patients with acute decompensated heart failure requiring intravenous diuretic therapy.

Official Title

Change in Stroke Volume Index After Diuresis for Patients With Decompensated Heart Failure

Quick Facts

Study Start:2022-08-30
Study Completion:2025-07-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05240651

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Diagnosis of congestive acute decompensated heart failure (preserved or reduced ejection fraction) requiring clinically indicated IV diuresis
  2. 2. Admission to coronary/cardiac intensive care unit or cardiac step down unit
  3. 3. Able to provide written informed consent
  4. 4. Anticipated need for IV diuretics \> 24 hrs
  1. 1. Prisoner, pregnancy or post-partum stage, or age \< 18 years
  2. 2. Known allergy to sensory material or gel
  3. 3. End stage renal disease or need for CRRT
  4. 4. Inability or contraindication to do a passive leg raise with both extremities (i.e., balloon pump, impella, spinal injury, amputation)
  5. 5. Other situation that might increase subject risk, interfere with study procedures, or confound study findings based on the opinion of the clinician/investigator
  6. 6. Inability to provide informed consent

Contacts and Locations

Study Contact

Carlos Alviar, MD
CONTACT
212-263-6635
carlos.alviar@nyulangone.org

Principal Investigator

Carlos Alviar, MD
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

NYU Langone Health
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Carlos Alviar, MD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-08-30
Study Completion Date2025-07-01

Study Record Updates

Study Start Date2022-08-30
Study Completion Date2025-07-01

Terms related to this study

Additional Relevant MeSH Terms

  • Acute Decompensated Heart Failure